Tumor- and CRC-specific mutations were mostly synonymous or low-impact variants in genes including AKT1 (YCLO-2), BRAF (YCLO-2), FGFR3 (YCLO-7), and PIK3R1 (YCLO-7). Here, AKT1 is linked to neoplasm.